AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32521358 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 162
Study 32521358 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIN-CHAT Program
Number of subjects: 162
Study 34134579 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab injecta (40 mg)
Number of subjects: 164
Study 34134579 — intervention group
Group type: COMPARATOR
Intervention: Humira® (40 mg)
Number of subjects: 164
Study 34134579 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab injecta
Number of subjects: 164
Study 34134579 — intervention group
Group type: COMPARATOR
Intervention: Humira®
Number of subjects: 164
Study 34735452 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance-based group intervention conducted three months post-RYGB, consisting of four group sessions.
Number of subjects: 259
Study 34735452 — intervention group
Group type: COMPARATOR
Intervention: Standard post-surgery care (control group).
Number of subjects: 259
Study 35057579 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mL baobab aqueous extract (BAE)
Number of subjects: 31
Study 35057579 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral glucose tolerance test (OGTT))
Number of subjects: 31
Study 34526321 — intervention group
Group type: EXPERIMENTAL
Intervention: Household-based community health worker programme
Number of subjects: 120000
Study 34758210 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered group cognitive-behavioral therapy (CBT) for postpartum depression (PPD)
Number of subjects: 73
Study 34758210 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 73
Study 33849091 — intervention group
Group type: EXPERIMENTAL
Intervention: EVOSKIN PSMC
Number of subjects: 105
Study 33849091 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 105
Study 34633116 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab 210 mg sc every month for 2 months
Number of subjects: 29
Study 34633116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 34870069 — intervention group
Group type: EXPERIMENTAL
Intervention: Gym participation program for 6 months
Number of subjects: 19
Study 32493881 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (3.75 mg/day)
Number of subjects: 3753
Study 32493881 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/day)
Number of subjects: 3753
Study 36286886 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth-based quadruple therapy with Bifiform (omeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg, bismuth tripotassium dicitrate 240 mg, Bifiform 2 capsules 2 times a day for 14 days)
Number of subjects: 68
Study 36286886 — intervention group
Group type: COMPARATOR
Intervention: Control group therapy (same as main group but without Bifiform)
Number of subjects: 68
Study 36286886 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth-based quadruple therapy with Bifiform
Number of subjects: 68
Study 35415940 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐MIST alone
Number of subjects: 45
Study 35415940 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐MIST + EMD
Number of subjects: 45
Study 35415940 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐MIST + EMD + BMDX
Number of subjects: 45
Study 33277803 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count (PLT) > 105 × 10^9/L
Number of subjects: 436
Study 33277803 — intervention group
Group type: COMPARATOR
Intervention: Baveno VI criteria
Number of subjects: 436
Study 33542229 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 7489
Study 33542229 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-to-Hip Ratio (WHR)
Number of subjects: 7489
Study 34253806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold bubbled humidified oxygen therapy (OX + HUMID)
Number of subjects: 31
Study 34253806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold bubbled humidified compressed air (CA + HUMID)
Number of subjects: 31
Study 34253806 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry oxygen therapy (OX + DRY)
Number of subjects: 31
Study 34253806 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry compressed air (CA + DRY)
Number of subjects: 31
Study 33167877 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Early Supported Discharge (VESD)
Number of subjects: 140
Study 33167877 — intervention group
Group type: COMPARATOR
Intervention: Standard Discharge
Number of subjects: 140
Study 33167877 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-confidence in postural balance
Number of subjects: 140
Study 33167877 — intervention group
Group type: COMPARATOR
Intervention: Very Early Supported Discharge (VESD) and Standard Discharge
Number of subjects: 140
Study 36499313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenerimod 0.5 mg
Number of subjects: 24
Study 36499313 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenerimod 4 mg
Number of subjects: 24
Study 36499313 — intervention group
Group type: COMPARATOR
Intervention: COC alone
Number of subjects: 24
Study 36499313 — intervention group
Group type: EXPERIMENTAL
Intervention: COC with cenerimod 4 mg
Number of subjects: 24
Study 33416994 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach CISB
Number of subjects: 54
Study 33416994 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach CISB
Number of subjects: 54
Study 33416994 — intervention group
Group type: COMPARATOR
Intervention: Catheters with tip migration
Number of subjects: 54
Study 34299962 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation through telerehabilitation tools
Number of subjects: 40
Study 34299962 — intervention group
Group type: COMPARATOR
Intervention: No physical activity (Control group)
Number of subjects: 40
Study 32191595 — intervention group
Group type: EXPERIMENTAL
Intervention: Effleurage massage (5 minutes)
Number of subjects: 32
Study 32191595 — intervention group
Group type: COMPARATOR
Intervention: Control (no massage)
Number of subjects: 32
Study 35381080 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (intravenous ertapenem followed by oral levofloxacin and metronidazole)
Number of subjects: 72
Study 35381080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 33752446 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 50)
Number of subjects: 160
Study 33752446 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) (n = 37)
Number of subjects: 160
Study 35201260 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrating Machine Learning Mortality Estimates with Behavioral Nudges to Clinicians
Number of subjects: 0
Study 35201260 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33781638 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy (ciNPT)
Number of subjects: 294
Study 33781638 — intervention group
Group type: COMPARATOR
Intervention: Silver-impregnated antimicrobial dressing (AMD)
Number of subjects: 294
Study 34986178 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV10
Number of subjects: 45398
Study 34986178 — intervention group
Group type: COMPARATOR
Intervention: Control (hepatitis B/A vaccine)
Number of subjects: 45398
Study 35932699 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic cat therapy (20 min/week for 2 months)
Number of subjects: 54
Study 35932699 — intervention group
Group type: EXPERIMENTAL
Intervention: Betta fish therapy (kept at home for 2 months)
Number of subjects: 54
Study 35932699 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 33395924 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (SAL) 400 µg
Number of subjects: 19
Study 33395924 — intervention group
Group type: COMPARATOR
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 19
Study 32043907 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotersen 300 mg/week
Number of subjects: 81
Study 32043907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 35072273 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a female experimenter
Number of subjects: 299
Study 35072273 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a male experimenter
Number of subjects: 299
Study 35072273 — intervention group
Group type: COMPARATOR
Intervention: No experimenter present
Number of subjects: 299
Study 33851246 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient physical therapy (superficial heater + deep heater + transcutaneous electrical nerve stimulation) for 2 weeks and spa therapy
Number of subjects: 74
Study 33851246 — intervention group
Group type: COMPARATOR
Intervention: Inpatient physical therapy (superficial heater + deep heater + transcutaneous electrical nerve stimulation) for 2 weeks and spa therapy
Number of subjects: 74
Study 36191949 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 8252
Study 36191949 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 8252
Study 36191949 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 8252
Study 34165343 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 0
Study 32234653 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein formula (1.89 g protein/100 kcal)
Number of subjects: 80
Study 32234653 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein formula (2.1 g protein/100 kcal)
Number of subjects: 80
Study 32234653 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed reference group
Number of subjects: 80
Study 34238227 — intervention group
Group type: EXPERIMENTAL
Intervention: cFMT (frozen encapsulated fecal microbiota transplantation)
Number of subjects: 12
Study 34238227 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 12
Study 34238227 — intervention group
Group type: EXPERIMENTAL
Intervention: cFMT
Number of subjects: 12
Study 32740903 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sodium valproate (iVPA)
Number of subjects: 682
Study 36206023 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect Adventures games
Number of subjects: 38
Study 36206023 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy protocol
Number of subjects: 38
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-1 in stage 1 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-2 in stage 1 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-3 in stage 1 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-4 in stage 1 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-1 in stage 2 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-2 in stage 2 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-3 in stage 2 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-4 in stage 2 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-1 in stage 3 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-2 in stage 3 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-3 in stage 3 CKD
Number of subjects: 1159
Study 34311597 — intervention group
Group type: EXPERIMENTAL
Intervention: CPITN-4 in stage 3 CKD
Number of subjects: 1159
Study 32125665 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone 20 mg orally
Number of subjects: 82
Study 35170528 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine and adefovir
Number of subjects: 0
Study 35170528 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide with age, gender, HBV DNA, core promoter mutations and cirrhosis (GAG-HCC)
Number of subjects: 0
Study 35170528 — intervention group
Group type: EXPERIMENTAL
Intervention: Taiwanese HBV cohort (TW1)
Number of subjects: 0
Study 35170528 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH-B
Number of subjects: 0
Study 34911689 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction group
Number of subjects: 136
Study 34911689 — intervention group
Group type: COMPARATOR
Intervention: Expectant management group
Number of subjects: 136
Study 35509110 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser followed by triamcinolone acetonide application
Number of subjects: 30
Study 35509110 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling followed by triamcinolone acetonide application
Number of subjects: 30
Study 35509110 — intervention group
Group type: COMPARATOR
Intervention: Comparison between fractional CO2 laser and microneedling
Number of subjects: 30
Study 32091597 — intervention group
Group type: EXPERIMENTAL
Intervention: AHEI-2010 second quintile
Number of subjects: 8461
Study 32091597 — intervention group
Group type: EXPERIMENTAL
Intervention: AHEI-2010 third quintile
Number of subjects: 8461
Study 32091597 — intervention group
Group type: EXPERIMENTAL
Intervention: AHEI-2010 fourth quintile
Number of subjects: 8461
Study 32091597 — intervention group
Group type: EXPERIMENTAL
Intervention: AHEI-2010 fifth quintile
Number of subjects: 8461
Study 37442218 — intervention group
Group type: EXPERIMENTAL
Intervention: Swiss ball stabilization training (SBST)
Number of subjects: 30
Study 37442218 — intervention group
Group type: COMPARATOR
Intervention: Stable surface stabilization training (SSST)
Number of subjects: 30
Study 33583360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cecolin® vaccine with ISARs (local pain, induration, swelling, systemic fever)
Number of subjects: 0
Study 33583360 — intervention group
Group type: COMPARATOR
Intervention: Cecolin® vaccine without ISARs
Number of subjects: 0
Study 33583360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cecolin® vaccine (high ISAR score)
Number of subjects: 0
Study 33583360 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis E vaccine
Number of subjects: 0
Study 32562682 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management alone
Number of subjects: 226
Study 32562682 — intervention group
Group type: COMPARATOR
Intervention: Medical management plus interventional therapy
Number of subjects: 226
Study 34609621 — intervention group
Group type: EXPERIMENTAL
Intervention: PROT (advice to increase protein intake to ≥ 1.2 g/kg aBW/d)
Number of subjects: 276
Study 34609621 — intervention group
Group type: EXPERIMENTAL
Intervention: PROT + TIMING (similar advice plus advice to consume protein-enriched foods within half an hour after usual physical activity)
Number of subjects: 276
Study 34609621 — intervention group
Group type: EXPERIMENTAL
Intervention: PROT
Number of subjects: 276
Study 34609621 — intervention group
Group type: EXPERIMENTAL
Intervention: PROT + TIMING
Number of subjects: 276
Study 34609621 — intervention group
Group type: COMPARATOR
Intervention: CON (continue the habitual diet with no advice)
Number of subjects: 276
Study 33704808 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically proxied LDL-c levels
Number of subjects: 173082
Study 33704808 — intervention group
Group type: COMPARATOR
Intervention: Survival to the 90th vs 60th percentile age
Number of subjects: 173082
Study 33704808 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-c modification through PCSK9
Number of subjects: 173082
Study 34988957 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 60
Study 34988957 — intervention group
Group type: COMPARATOR
Intervention: Infiltration block
Number of subjects: 60
Study 33509352 — intervention group
Group type: EXPERIMENTAL
Intervention: Short taper of steroids over 36 days after remission
Number of subjects: 0
Study 32326966 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemp seed protein (HSP)
Number of subjects: 35
Study 32326966 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemp seed protein plus HSP hydrolysate (HSP+)
Number of subjects: 35
Study 32326966 — intervention group
Group type: COMPARATOR
Intervention: Casein protein
Number of subjects: 35
Study 32326966 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (HSP, HSP+, Casein)
Number of subjects: 35
Study 34704428 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance training with blood flow restriction at 50 mmHg
Number of subjects: 39
Study 34704428 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance training with blood flow restriction at 75 mmHg
Number of subjects: 39
Study 34704428 — intervention group
Group type: COMPARATOR
Intervention: Exercise training without restrictive pressure (Control group A)
Number of subjects: 39
Study 34704428 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 39
Study 33159971 — intervention group
Group type: EXPERIMENTAL
Intervention: Dummy run brachytherapy planning
Number of subjects: 27
Study 33159971 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual quality assurance
Number of subjects: 27
Study 32501914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous EACA
Number of subjects: 24
Study 32501914 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study 33094434 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitivity C reactive protein (hs‐CRP) levels in bipolar disorder patients
Number of subjects: 56
Study 33094434 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 56
Study 33094434 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐CRP elevation in bipolar patients
Number of subjects: 56
Study 32600060 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot Assisted Kidney Transplant (RAKT)
Number of subjects: 55
Study 32600060 — intervention group
Group type: COMPARATOR
Intervention: Open Kidney Transplant (OKT)
Number of subjects: 55
Study 35965631 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous care combined with respiratory exercise care model
Number of subjects: 120
Study 35965631 — intervention group
Group type: COMPARATOR
Intervention: Conventional care methods
Number of subjects: 120
Study 34314254 — intervention group
Group type: EXPERIMENTAL
Intervention: Chosen sound for 2 weeks
Number of subjects: 33
Study 34314254 — intervention group
Group type: COMPARATOR
Intervention: Study sound (broadband noise at hearing threshold) for 2 weeks
Number of subjects: 33
Study 34314254 — intervention group
Group type: EXPERIMENTAL
Intervention: Chosen sound
Number of subjects: 33
Study 34314254 — intervention group
Group type: EXPERIMENTAL
Intervention: App usage during at-home trial
Number of subjects: 33
Study 33158856 — intervention group
Group type: EXPERIMENTAL
Intervention: Values affirmation exercise
Number of subjects: 0
Study 33158856 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 35166684 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartband (Mi Band 2) and app (Mi Fit) with midwife counseling
Number of subjects: 150
Study 35166684 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 150
Study 33653815 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidiabetic drug users (including insulin and metformin)
Number of subjects: 6537
Study 33653815 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidiabetic drug users
Number of subjects: 6537
Study 33653815 — intervention group
Group type: COMPARATOR
Intervention: Nonusers of antidiabetic medication
Number of subjects: 6537
Study 32062808 — intervention group
Group type: EXPERIMENTAL
Intervention: Choroidal vascularity index (CVI) measurement in FUS eyes
Number of subjects: 39
Study 32062808 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial cell density (ECD) measurement in FUS eyes
Number of subjects: 39
Study 34914216 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil combined with behavioral therapy and psychological counseling
Number of subjects: 338
Study 34914216 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil alone
Number of subjects: 338
Study 35502334 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine as a local anesthetic at the puncture site prior to IVC
Number of subjects: 77
Study 35502334 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 77
Study 32628523 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention in respiratory pathophysiology (2018)
Number of subjects: 201
Study 32628523 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention for students scoring below the median
Number of subjects: 201
Study 32628523 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention for male students
Number of subjects: 201
Study 32628523 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention for students without academic delay
Number of subjects: 201
Study 32628523 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention overall perception
Number of subjects: 201
Study 32628523 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method in blood pathophysiology (2017 and 2018)
Number of subjects: 201
Study 35543710 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR) - outpatient, three weekly sessions for 3 months
Number of subjects: 41
Study 35543710 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (usual care + airway clearance therapy + breathing exercises)
Number of subjects: 41
Study 33896810 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic Control training (n=9)
Number of subjects: 18
Study 33896810 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=9)
Number of subjects: 18
Study 33502222 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel Ischemia Score (BIS) of 0 or 1
Number of subjects: 275
Study 33502222 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel Ischemia Score (BIS) of 3
Number of subjects: 275
Study 33502222 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel Ischemia Score (BIS)
Number of subjects: 275
Study 32188284 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed sutures (running closure)
Number of subjects: 60